The VA Million Veteran Program,Alzheimer's disease,and genetics: Important steps forward but many steps still to go on the march to control dementia and Alzheimer's disease
Restricted accessArticle commentaryFirst published online March, 2025
The VA Million Veteran Program,Alzheimer's disease,and genetics: Important steps forward but many steps still to go on the march to control dementia and Alzheimer's disease
The VA Million Veteran Program (MVP) is a nationwide initiative that seeks to examine how genes influence health and behaviors in military veterans. An article by Merritt et al. analyzing data from the MVP, developing and testing algorithms to query dementia and Alzheimer's disease (AD) diagnoses from the VA's electronic health record system and examining genetic factors, provides an extraordinarily important contribution to the dementia and AD fields. The analyses presented in the article show how large databases can be used to further understand dementia and AD, pointing the way for many more important advances for this field.
MerrittVCZhangRShervaR, et al.Curation and validation of electronic medical record based dementina diagnoses in the VA Million Veteran Program. J Alzheimers Dis 103. DOI: https://doi.org/10.1177/13872877241299130
2.
BellenguezCKucukaliFJansenIE, et al.New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet2022; 54: 412–436.
3.
AshfordJW. Treatment of Alzheimer's disease: the legacy of the cholinergic hypothesis, neuroplasticity, and future directions. J Alzheimers Dis2015; 47: 149–156.
4.
OriaRBSmithCJAshfordJW, et al.Pros and cons of APOE4 homozygosity and effects on neuroplasticity, malnutrition, and infections in early life adversity, Alzheimer's disease, and Alzheimer's prevention. J Alzheimers Dis2024; 100: S179–S185.
5.
AshfordJWSchmittFABergeronMF, et al.Now is the time to improve cognitive screening and assessment for clinical and research advancement. J Alzheimers Dis2022; 87: 305–315.
6.
GavrilovLAGavrilovaNS. Exploring patterns of human mortality and aging: a reliability theory viewpoint. Biochemistry (Mosc)2024; 89: 341–355.
7.
AshfordJW. Screening for memory disorders, dementia, and Alzheimer's disease. Aging Health2008; 4: 399–432.
8.
JormAFJolleyD. The incidence of dementia: a meta-analysis. Neurology1998; 51: 728–733.
9.
AshfordJW. APOE Genotype effects on Alzheimer's disease onset and epidemiology. J Mol Neurosci2004; 23: 157–166.
10.
RaberJHuangYAshfordJW. Apoe genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging2004; 25: 641–650.
11.
BelloyMEAndrewsSJLe GuenY, et al.APOE Genotype and Alzheimer disease risk across age, sex, and population ancestry. JAMA Neurol2023; 80: 1284–1294.
12.
CorderEHSaundersAMStrittmatterWJ, et al.Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science1993; 261: 921–923.
13.
ForteaJPeguerolesJAlcoleaD, et al.APOE4 Homozygozity represents a distinct genetic form of Alzheimer's disease. Nat Med2024; 30: 1284–1291.
14.
FrankLWesson AshfordJBayleyPJ, et al.Genetic risk of Alzheimer's disease: three wishes now that the genie is out of the bottle. J Alzheimers Dis2018; 66: 421–423.
15.
WeinerMWFriedlKEPacificoA, et al.Military risk factors for Alzheimer's disease. Alzheimers Dement2013; 9: 445–451.
16.
SordilloJEDeyAHoYL, et al.Military and occupational exposures among Veterans in the Million Veteran Program by survey self-report: a descriptive study. Occup Environ Med2024; 81: 522–528.
17.
HarringtonKMQuadenRSteeleL, et al.The Million Veteran Program 1990-1991 Gulf War Era Survey: an evaluation of Veteran response, characteristics, and representativeness of the Gulf War Era Veteran Population. Int J Environ Res Public Health2024; 21: 72.
18.
AdlerJSOzturkEDMerrittVC, et al.Prospective memory performance in veterans with and without histories of mild traumatic brain injury: effect of the apolipoprotein E (APOE) epsilon4 genotype. J Clin Exp Neuropsychol2024; 46: 352–363.
19.
MerrittVCGasperiMYimJ, et al.Exploring interactions between traumatic brain injury history and gender on medical comorbidities in military Veterans: an epidemiological analysis in the VA Million Veteran Program. J Neurotrauma2024; 41: 623–634.
20.
AshfordJWBorsonSO’HaraR, et al.Should older adults be screened for dementia? It is important to screen for evidence of dementia. Alzheimers Dement2007; 3: 75–80.
21.
BorsonSFrankLBayleyPJ, et al.Improving dementia care: the role of screening and detection of cognitive impairment. Alzheimers Dement2013; 9: 151–159.
22.
DuboisBPadovaniAScheltensP, et al.Timely diagnosis for Alzheimer's disease: a literature review on benefits and challenges. J Alzheimers Dis2016; 49: 617–631.
23.
HampelHVergalloAIwatsuboT, et al.Evaluation of major national dementia policies and health-care system preparedness for early medical action and implementation. Alzheimers Dement2022; 18: 1993–2002.
24.
ThunellJAJacobsonMJoeEB, et al.Medicare's annual wellness visit and diagnoses of dementias and cognitive impairment. Alzheimers Dement (Amst)2022; 14: e12357.
25.
TzengHMRajiMAShanY, et al.Annual wellness visits and early dementia diagnosis among Medicare beneficiaries. JAMA Netw Open2024; 7: e2437247.
26.
JacobsonMThunellJZissimopoulosJ. Cognitive assessment at Medicare's annual wellness visit in fee-for-service and medicare advantage plans. Health Aff (Millwood)2020; 39: 1935–1942.
27.
AshfordJWCliffordJOBergeronMF. Advancing screening for cognitive impairment: the memtrax continuous recognition test. Aging (Albany NY)2023; 15: 5230–5231.
28.
AlibertiMJRAvelino-SilvaTJSuemotoCK. Maximizing early dementia detection through Medicare annual wellness visits. JAMA Netw Open2024; 7: e2437162.
29.
AshfordJWSchmittFAKumarV. Diagnosis of Alzheimer's disease. Psychiatric Annals1996; 26: 262–268.
30.
KaranthSNelsonPTKatsumataY, et al.Prevalence and clinical phenotype of quadruple misfolded proteins in older adults. JAMA Neurol2020; 77: 1299–1307.
31.
AshfordJW. Neuroplasticity: the critical issue for Alzheimer's disease and links to obesity and depression. Am J Geriatr Psychiatry2023; 31: 867–875.
32.
Dams-O'ConnorKAwwadHOHoffmanS, et al.Alzheimer's Disease-Related Dementias Summit 2022: national research priorities for the investigation of post-traumatic brain injury Alzheimer's disease and related dementias. J Neurotrauma2023; 40: 1512–1523.
